v3.23.3
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021     75,754,663          
Beginning balance at Dec. 31, 2021 $ 829,155 $ (81,734) $ 76 $ 1,735,628 $ (114,551) $ (890,638) $ 32,817 $ (15,911)
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)     577,416          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (919)   $ 1 (920)        
Exercise of stock options (in shares)     284,455          
Exercise of stock options 875     875        
Stock-based compensation expense 24,424     24,424        
Net loss (125,780)         (125,780)    
Foreign currency translation adjustment 7,329             7,329
Ending balance (in shares) at Mar. 31, 2022     76,616,534          
Ending balance at Mar. 31, 2022 653,350   $ 77 1,645,456   (983,601)   (8,582)
Beginning balance (in shares) at Dec. 31, 2021     75,754,663          
Beginning balance at Dec. 31, 2021 829,155 $ (81,734) $ 76 1,735,628 $ (114,551) (890,638) $ 32,817 (15,911)
Increase (Decrease) in Stockholders' Equity                
Net loss (310,308)              
Foreign currency translation adjustment (5,982)              
Ending balance (in shares) at Sep. 30, 2022     77,845,436          
Ending balance at Sep. 30, 2022 493,916   $ 78 1,683,860   (1,168,129)   (21,893)
Beginning balance (in shares) at Mar. 31, 2022     76,616,534          
Beginning balance at Mar. 31, 2022 $ 653,350   $ 77 1,645,456   (983,601)   (8,582)
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock in connection with employee stock purchase plan (in shares) 136,039              
Issuance of common stock in connection with employee stock purchase plan $ 1,282     1,282        
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)     464,984          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (822)     (822)        
Exercise of stock options (in shares)     2,278          
Exercise of stock options 17     17        
Stock-based compensation expense 22,349     22,349        
Net loss (62,852)         (62,852)    
Foreign currency translation adjustment (7,674)             (7,674)
Ending balance (in shares) at Jun. 30, 2022     77,219,835          
Ending balance at Jun. 30, 2022 605,650   $ 77 1,668,282   (1,046,453)   (16,256)
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)     595,369          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (579)   $ 1 (580)        
Exercise of stock options (in shares)     30,232          
Exercise of stock options 191     191        
Stock-based compensation expense 15,967     15,967        
Net loss (121,676)         (121,676)    
Foreign currency translation adjustment (5,637)             (5,637)
Ending balance (in shares) at Sep. 30, 2022     77,845,436          
Ending balance at Sep. 30, 2022 $ 493,916   $ 78 1,683,860   (1,168,129)   (21,893)
Beginning balance (in shares) at Dec. 31, 2022 78,334,666   78,334,666          
Beginning balance at Dec. 31, 2022 $ 501,516   $ 78 1,700,855   (1,179,972)   (19,445)
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock in connection with employee stock purchase plan (in shares)     207,160          
Issuance of common stock in connection with employee stock purchase plan 1,177   $ 1 1,176        
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)     1,047,765          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (361)   $ 1 (362)        
Exercise of stock options (in shares)     17,166          
Exercise of stock options 110     110        
Stock-based compensation expense 14,563     14,563        
Net loss (54,062)         (54,062)    
Foreign currency translation adjustment (3,303)             (3,303)
Ending balance (in shares) at Mar. 31, 2023     79,606,757          
Ending balance at Mar. 31, 2023 $ 459,640   $ 80 1,716,342   (1,234,034)   (22,748)
Beginning balance (in shares) at Dec. 31, 2022 78,334,666   78,334,666          
Beginning balance at Dec. 31, 2022 $ 501,516   $ 78 1,700,855   (1,179,972)   (19,445)
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options (in shares) 17,166              
Net loss $ (275,159)              
Foreign currency translation adjustment $ (7,119)              
Ending balance (in shares) at Sep. 30, 2023 81,630,808   81,630,808          
Ending balance at Sep. 30, 2023 $ 256,479   $ 82 1,738,092   (1,455,131)   (26,564)
Beginning balance (in shares) at Mar. 31, 2023     79,606,757          
Beginning balance at Mar. 31, 2023 459,640   $ 80 1,716,342   (1,234,034)   (22,748)
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock in connection with employee stock purchase plan (in shares)     255,169          
Issuance of common stock in connection with employee stock purchase plan 925     925        
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)     1,095,728          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (375)   $ 1 (376)        
Stock-based compensation expense 10,983     10,983        
Net loss (173,654)         (173,654)    
Foreign currency translation adjustment (4,001)             (4,001)
Ending balance (in shares) at Jun. 30, 2023     80,957,654          
Ending balance at Jun. 30, 2023 293,518   $ 81 1,727,874   (1,407,688)   (26,749)
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)     673,154          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (221)   $ 1 (222)        
Stock-based compensation expense 10,440     10,440        
Net loss (47,443)         (47,443)    
Foreign currency translation adjustment $ 185             185
Ending balance (in shares) at Sep. 30, 2023 81,630,808   81,630,808          
Ending balance at Sep. 30, 2023 $ 256,479   $ 82 $ 1,738,092   $ (1,455,131)   $ (26,564)